NIH RePORTER
Cure8 research brief
Why This Matters
The project targets a molecular regulator of tuft cells, which help control mucosal immune responses and have been linked to chronic gut inflammation such as ulcerative colitis. Discovering how OCA-T2 shapes tuft cell development could reveal new biological targets relevant to IBD.
Who Should Pay Attention
Researchers studying epithelial biology, tuft cells, mucosal immunology, and the gut microbiome; translational IBD scientists; clinicians interested in the epithelial contributions to ulcerative colitis.
Study Snapshot
Story typeCompany update
Evidence typeFunded research project
Study statusFunded
Source depthResearch project record
What To Know
This is a funded research project (project record) from Cold Spring Harbor Laboratory describing mouse genetic and molecular work to define OCA-T2’s role in tuft cell development.
The team has generated OCA-T2 knockout mice and observes loss of small intestinal and colonic tuft cells, and plans aimed at characterizing intestinal inflammation and performing transcriptomic and epigenomic assays (including single-cell RNA-seq and ATAC-seq) to define how OCA-T2 shapes tuft cell identity.
The work is preclinical and mechanistic: it reports genetic models and plans for sequencing- and chromatin-based experiments rather than clinical interventions or patient data. Any implications for therapies in IBD are exploratory and would require many follow-up studies.
Keep In Mind
This entry is a funded project record describing planned and ongoing preclinical research in mice and cell lines. It is not a clinical trial or a report of patient outcomes. Findings in mouse genetic models and in vitro systems may not directly translate to humans without further validation.
Source Details
Review the original publication for the complete reporting, methods, and context.
Funded research project
Evidence type derived from source or registry metadata.
PublicationNIH RePORTER
AuthorsLiam P Shanley
InstitutionCOLD SPRING HARBOR LABORATORY
Study typeFunded Research Project
Indexed viaNIH RePORTER
Source typeFunded research record
PublishedSep 16, 2026, 12:00 AM
Content availableResearch project record
Funding disclosed by the source: National Institute of Diabetes and Digestive and Kidney Diseases - F31DK145216 - $34,114
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The regulatory role of post-translational modifications in the pathogenesis of ulcerative colitis
Understanding PTMs may help researchers identify new biomarkers or therapeutic targets for ulcerative colitis, which could eventually lead to better treatments or tests. For people with UC, this explains part of why...
From signals to systems: the epigenetic-microbiome-mitochondrial axis in IBD pathogenesis.
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Multi-Omics Framework Integrating Genetics, Microbiome, Metabolism, and Immunity for Deciphering Ulcerative Colitis Pathogenesis and Diagnostic Biomarker Discovery.
Researchers used genetics, microbiome, metabolism, and immune profiling together to nominate biological pathways and a four-gene signature that might help diagnose or explain ulcerative colitis. If validated later, these...